NEW YORK, Jan. 3, 2024 /PRNewswire/ — Carbyne, a leading innovator in emergency response technology and services, is proud to announce its inclusion in the prestigious GovTech 100 list for 2024. This recognition underscores Carbyne’s commitment to revolutionizing the way government agencies respond to emergencies, leveraging cutting-edge technology to ensure public safety and efficient services.… Continue reading Carbyne Named to the Prestigious GovTech 100 List for 2024
Category: Newswire
New book by a Papal Missionary of Mercy challenges readers to spend 60 seconds a day with Jesus
CHICAGO, Jan. 3, 2024 /PRNewswire/ — In his new book 60 Seconds for Jesus, Father Jim Sichko challenges readers to take 60 seconds a day to find and experience God’s love. Father Jim refers to 60 Seconds with Jesus as a “Do-votional” because it gives readers specific actions they can do to find purpose and possibility.… Continue reading New book by a Papal Missionary of Mercy challenges readers to spend 60 seconds a day with Jesus
Guest Services, Inc. Invites Travelers to Embrace the Outdoors with Adventures Unbound
New Brand from Leading Hospitality Company Offers Ultimate Opportunity for Outdoor Enthusiasts FAIRFAX, Va., Jan. 3, 2024 /PRNewswire/ — Today’s travel enthusiast seeks more than just a vacation; they seek a personal connection to the unforgettable outdoors. Adventures Unbound, the new brand from venerable hospitality company, Guest Services, Inc., embraces this spirit, enabling travelers to rediscover… Continue reading Guest Services, Inc. Invites Travelers to Embrace the Outdoors with Adventures Unbound
MAPLIGHT THERAPEUTICS ANNOUNCES COMPLETION OF PHASE 1 CLINICAL TRIAL FOR NOVEL M1/M4 MUSCARINIC AGONIST IN DEVELOPMENT FOR SCHIZOPHRENIA AND ALZHEIMER’S DISEASE PSYCHOSIS
Extended-release ML-007 was evaluated for safety, tolerability, and pharmacokinetic profile in healthy volunteers across several dosing regimens, alone and when co-administered with an extended-release muscarinic antagonist Extended-release ML-007 was well tolerated at all doses including doses at and above those planned for use in the company’s upcoming Phase 2 trials for the treatment of schizophrenia… Continue reading MAPLIGHT THERAPEUTICS ANNOUNCES COMPLETION OF PHASE 1 CLINICAL TRIAL FOR NOVEL M1/M4 MUSCARINIC AGONIST IN DEVELOPMENT FOR SCHIZOPHRENIA AND ALZHEIMER’S DISEASE PSYCHOSIS
Origin Investments Announces Availability of Funds on iCapital Marketplace
Financial advisers seeking to diversify client portfolios with alternative investments in private real estate have two new options on digital investment platform iCapital Marketplace—multifamily Funds from Origin Investments and Origin Credit Advisers aimed at enhancing portfolio yield and total return while reducing volatility and maximizing diversification. CHICAGO, Jan. 3, 2024 /PRNewswire/ — Multifamily real estate… Continue reading Origin Investments Announces Availability of Funds on iCapital Marketplace
True Elements and Carahsoft Partner to Bring Water Intelligence Solutions to the Public Sector
Powerful SaaS and Data Set Solutions Now Available to Federal, State and Local Government Agencies NAPLES, Fla. and RESTON, Va., Jan. 3, 2024 /PRNewswire/ — True Elements, the leader in Water Intelligence, and Carahsoft Technology Corp., The Trusted Government IT Solutions Provider®, today announced a partnership. Under the agreement, Carahsoft will serve as True Elements’ Master Government… Continue reading True Elements and Carahsoft Partner to Bring Water Intelligence Solutions to the Public Sector
STEMILT GROWERS POSITIONED FOR CONTINUED COMPANY GROWTH IN 2024
On the Heels of a Record Year, Leader in Tree Fruits Looks Ahead to Ongoing Innovation, Increased Crop Yield, and Expanded Operations WENATCHEE, Wash., Jan. 3, 2024 /PRNewswire/ — Stemilt Growers, leading packer, grower, and distributor of tree fruits, including apples and pears, celebrates the close of another incredible year in its multi-generational history. At the… Continue reading STEMILT GROWERS POSITIONED FOR CONTINUED COMPANY GROWTH IN 2024
KeyBank Foundation Invests More than $6 Million in 12 Cleveland Area Non-Profit Organizations
Chosen community organizations will use grant dollars to improve the lives of Northeast Ohioans CLEVELAND, Jan. 3, 2024 /PRNewswire/ — KeyBank and the KeyBank Foundation announced it has supported twelve non-profit organization in 2023 with grants totaling more than $6 million to further their missions of improving Northeast Ohio. The grant dollars will support workforce development,… Continue reading KeyBank Foundation Invests More than $6 Million in 12 Cleveland Area Non-Profit Organizations
Die neue Open-E JovianDSS Up30 Version ermöglicht Datentyp-Tiering und NVMe Partitionierung
Open-E hat die Freigabe der neuen Version von Open-E JovianDSS Up30 bekannt gegeben, die einen Durchbruch darstellt. ATLANTA, 3. Januar 2024 /PRNewswire/ — Open-E, ein führender Entwickler von softwaredefinierten Speicherlösungen, gibt die Freigabe der neuen Open-E JovianDSS Up30-Version bekannt. Dieses bahnbrechende Update bringt eine Vielzahl von fortschrittlichen Funktionen und Verbesserungen, die die Leistung, Zuverlässigkeit und Sicherheit… Continue reading Die neue Open-E JovianDSS Up30 Version ermöglicht Datentyp-Tiering und NVMe Partitionierung
Nueva versión Open-E JovianDSS Up30: organización por niveles de tipos de datos y partición NVMe
La nueva versión Open-E JovianDSS Up30 permite la organización por niveles de tipos de datos y la partición NVMe Open-E anunció el lanzamiento de la nueva versión innovadora de Open-E JovianDSS Up30. ATLANTA, 3 de enero de 2024 /PRNewswire/ — Open-E, un desarrollador líder de soluciones de almacenamiento definido por software, anuncia el lanzamiento de la… Continue reading Nueva versión Open-E JovianDSS Up30: organización por niveles de tipos de datos y partición NVMe